Consistently, amplification of SOX4 in human breast cancers has been shown to promote PI3K-AKT signaling52, and SOX4 was identified as a critical activator of PI3K-AKT to enable oncogenic survival signals in leukemia53. This evidence concerns the gene AKT1 and breast cancer.